FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a mononuclear dinitrosyl ferric complex of general formula (N2H5)+[Fe(SR)2(NO)2]-, wherein R represents 5-nitropyridyl, as well as 2-nitro-, 3-nitro- and 4-nitrophenyls and pyridinyls. There are also presented a method for preparing the mononuclear dinitrosyl ferric complex, nitrogen monoxide donor and using the mononuclear dinitrosyl ferric complex.
EFFECT: invention enables preparing the new dinitrosyl ferric complexes which may be used as the anti-tumour drugs.
2 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SINGLE-NUCLEAR CATIONIC DINITROSYL IRON COMPLEXES, METHOD FOR PRODUCING THEM, NITROGEN MONOXIDE DONOR | 2014 |
|
RU2567245C1 |
| USE OF NITROSYL IRON COMPLEX WITH N,N-DIETHYLTHIOUREA AS NEW NO-DONOR ANTICANCER AGENT | 2016 |
|
RU2687269C2 |
| USE OF BINUCLEAR SULPHUR-NITROSYL CATIONIC IRON COMPLEX AS VASODILATATOR | 2010 |
|
RU2460531C2 |
| APPLICATION OF BINUCLEAR SULPHUR-NITROSYL COMPLEX OF ANION TYPE IRON AS VASODEPRESSOR MEDICATION | 2010 |
|
RU2437667C1 |
| AGENT WITH ANTIVIRAL ACTIVITY AGAINST SARS-COV-2 AND METHOD OF USING THE SAME | 2022 |
|
RU2797619C1 |
| BINUCLEAR NITROSYL IRON COMPLEXES WITH BENZAZEHETEROCYCLIC DERIVATIVES, WAYS OF ITS PRODUCTION | 2007 |
|
RU2441872C2 |
| WATER-SOLUBLE BINUCLEAR CATION NITROSYL IRON COMPLEXES WITH NATURAL ALIPHATIC THIOLYLS POSSESSING CYTOTOXIC, APOPTOTIC AND NO-DONOR ACTIVITY | 2008 |
|
RU2441873C2 |
| METHOD OF DETECTING NITROSO-COMPOUNDS AND NITRITE IN BIOLOGICAL OBJECTS | 2008 |
|
RU2395096C2 |
| SUPRAMOLECULAR ASSEMBLIES OF DINITROSYL IRON COMPLEXES, METHOD OF THEIR PREPARATION, NITROGEN MONOXIDE DONORS, PHOSPHODIESTERASE INHIBITORS, USE OF SUPRAMOLECULAR ASSEMBLIES OF DINITROSYL IRON COMPLEXES AS ANTI-INFLAMMATORY MEDICINAL PRODUCTS | 2023 |
|
RU2814108C1 |
| USING TETRANITROSYL COMPLEX OF IRON WITH THIOPHENOL AS ANTI-TUMOUR MEDICINAL AGENT | 2007 |
|
RU2429242C2 |
